1: Yamamoto T, Takahara K, Inai T, Node K, Teramoto N. Molecular analysis of ATP-sensitive K(+) channel subunits expressed in mouse portal vein. Vascul Pharmacol. 2015 Dec;75:29-39. doi: 10.1016/j.vph.2015.06.018. Epub 2015 Jul 8. PubMed PMID: 26163942.
2: Iwasa K, Zhu HL, Shibata A, Maehara Y, Teramoto N. Molecular analysis of ATP-sensitive K⁺ channel subunits expressed in mouse vas deferens myocytes. Br J Pharmacol. 2014 Jan;171(1):145-57. doi: 10.1111/bph.12437. PubMed PMID: 24117345; PubMed Central PMCID: PMC3874703.
3: Naryzhnaia NV, Neckar J, Maslov LN, Lishmanov IuB, Kolar F, Lasukova TV. [The role of sarcolemmal and mitochondrial K(ATP)-channels in realization of the cardioprotection and antiarrhythmic effect of different regimens of hypobaric adaptation]. Ross Fiziol Zh Im I M Sechenova. 2009 Aug;95(8):837-49. Russian. PubMed PMID: 19803213.
4: Kolar F, Nekar J, Ostadal B, Maslov LN, Stakheev DL, Tayurskaya AS, Lishmanov YB. Role of ATP-sensitive K(+)-channels in antiarrhythmic and cardioprotective action of adaptation to intermittent hypobaric hypoxia. Bull Exp Biol Med. 2008 Apr;145(4):418-21. PubMed PMID: 19110582.
5: Kolár F, Neckár J, Ostádal B. MCC-134, a blocker of mitochondrial and opener of sarcolemmal ATP-sensitive K+ channels, abrogates cardioprotective effects of chronic hypoxia. Physiol Res. 2005;54(4):467-71. PubMed PMID: 16117602.
6: Yunoki T, Teramoto N, Takano N, Seki N, Creed KE, Naito S, Ito Y. The effects of MCC-134 on the ATP-sensitive K+ channels in pig urethra. Eur J Pharmacol. 2003 Dec 15;482(1-3):287-95. PubMed PMID: 14660034.
7: Yunoki T, Teramoto N, Ito Y. Functional involvement of sulphonylurea receptor (SUR) type 1 and 2B in the activity of pig urethral ATP-sensitive K+ channels. Br J Pharmacol. 2003 Jun;139(3):652-60. PubMed PMID: 12788825; PubMed Central PMCID: PMC1573868.
8: Sasaki N, Murata M, Guo Y, Jo SH, Ohler A, Akao M, O'Rourke B, Xiao RP, Bolli R, Marbán E. MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning. Circulation. 2003 Mar 4;107(8):1183-8. PubMed PMID: 12615799; PubMed Central PMCID: PMC3680097.
9: Morita H, Yamada K, Abe K, Ito Y, Inoue R. Electrophysiological actions of a novel K(+) channel opener MCC-134 on rabbit portal vein smooth muscle. Eur J Pharmacol. 1999 Nov 19;384(2-3):203-12. PubMed PMID: 10611443.
10: Shindo T, Katayama Y, Horio Y, Kurachi Y. MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K(+) channel. J Pharmacol Exp Ther. 2000 Jan;292(1):131-5. PubMed PMID: 10604939.